Global Drug Discovery Services Market, Trends & Analysis - Forecasts To 2026 By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), By Type (Medicinal Chemistry Services, Biology Services, Drug Metabolism & Pharmacokinetics), By Drug Type (Small-Molecule Drugs, Biologic Drugs), By Therapeutic Area (Oncology, Neurology , Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Other), By Company Type (Tier 1 Pharmaceutical Companies, Tier 2 Pharmaceutical Companies, Tier 3 Pharmaceutical Companies), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis
Drug Discovery Services Market: Insights
The global drug discovery services market is estimated to witness a significant CAGR during the forecast period (2019-2026). The growth of the drug discovery services market is anticipated to increase with the growing demand from pharmaceutical sector, increasing R&D activities and emergence of new diseases across the globe among others.
Drug Discovery Services Market: By Process
On the basis of process, the global drug discovery services market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. The report contains quantitative insights about the following
Drug Discovery Services Market: By Type
On the basis of type, the global drug discovery services market is segmented into medicinal chemistry services, biology services, and drug metabolism & pharmacokinetics. The report contains quantitative insights about the following
Drug Discovery Services Market: By Drug Type
On the basis of drug type, the global drug discovery services market is segmented into small-molecule drugs and biologic drugs. The report contains quantitative insights about the following
Drug Discovery Services Market: By Therapeutic Area
On the basis of therapeutic area, the global drug discovery services market is segmented into oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases and among other. The report contains quantitative insights about the following
Drug Discovery Services Market: By Company Type
On the basis of company type, the global drug discovery services market is segmented into tier 1 pharmaceutical companies, tier 2 pharmaceutical companies and tier 3 pharmaceutical companies. The report contains quantitative insights about the following:
Drug Discovery Services Market: By Region
On the basis of region, the global Drug Discovery Services market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The countries covered include: U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Saudi Arabia, UAE, and South Africa among others. The report provides qualitative & quantitative insights both at a regional as well as country level.
Drug Discovery Services Market: End Use Landscape
The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase drug discovery services. The key end-users of the markets are Abbot, MacLeod, SunPharma and GSK among others.
Drug Discovery Services Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Drug Discovery Services Market: Share & Competitor Analysis
Some of the key players operating in the drug discovery services market are America Holdings, Albany Molecular Research, Inc, Charles River Laboratories International, Inc, Evotec SE, Eurofins Scientific, WuXi AppTec, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., Pharmaceutical Product Development, LLC, Syngene International Ltd., and Selvita S.A. among others.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Drug Discovery Services market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
80% of our clients seek made-to-order reports. How do you want us to tailor yours?